Institute for Clinical and Translational Research

February 8, 2018

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

By Bill Snyder
elderly Asian mother and adult daughter
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

By Bill Snyder
November 1, 2012

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

By Bill Snyder
Clinical and translational research at Vanderbilt will be funded over the next five years, thanks to a $46 million renewal grant from the National Center for Advancing Translational Sciences. (Mary Donaldson/Vanderbilt)
July 12, 2012

Vanderbilt’s CTSA lands $46 million renewal

Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.

By Bill Snyder